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There is little evidence to inform provi-
sion of enteral or parenteral nutrition to 
infants with hypoxic ischaemic encepha-
lopathy (HIE) during and soon after ther-
apeutic hypothermia; as a consequence, 
clinical practice is both variable and 
changing. A 2014 UK survey found that 
79% (33 of 42) of responding neonatal 
units routinely withheld enteral nutrition 
during cooling; 3 years later, a similar 
survey found that 41% (20 of 49) of 
responding units reported withholding 
enteral nutrition.1 The latter study also 
reports wide variation in how, when and 
how much to feed, and in the use of paren-
teral nutrition. Internationally, practice is 
even more variable: withholding enteral 
feeds is practised almost universally2 in 
some countries, while in others, milk 
feeding during hypothermia is routine.3 
Here we discuss the limited evidence 
available to inform enteral and parenteral 
nutrition during therapeutic 
hypothermia.
EntEral nutritiOn
The landmark trials4 that provided evidence 
for the neurodevelopmental benefits of 
therapeutic hypothermia withheld milk 
feeds during hypothermia. It is therefore 
unsurprising that withholding or delaying 
enteral feeding is commonplace. A major 
rationale for this practice is to prevent 
necrotising enterocolitis (NEC). NEC is 
well described in term infants with HIE, but 
is rare: among 11 trials, with a total of 1505 
infants, included in the Cochrane review of 
therapeutic hypothermia only three trials 
reported data on NEC and only one case was 
identified (in the hypothermia arm of the 
TOBY (Whole Body Hypothermia for the 
Treatment of Perinatal Asphyxial Encepha-
lopathy) trial.4 Although the pathogenesis 
of NEC is incompletely understood, one 
putative mechanism links the combination 
of impaired gastrointestinal blood flow (as 
seen in infants with HIE) and intraluminal 
substrate (such as milk) to the proinflam-
matory cascade that leads to gut necrosis 
and NEC. As a consequence, ‘prevention of 
NEC’ is a common reason for withholding 
enteral feeds in infants receiving thera-
peutic hypothermia for HIE, despite lack 
of evidence that withholding enteral feeds 
in other high-risk groups (such as preterm 
infants) reduces the incidence of NEC.5 6
The gut plays a crucial role in the patho-
physiology of critical illnesses such as HIE 
and NEC. The epithelial lining of the gut 
acts as a barrier, and plays an important 
role in preventing translocation of bacteria 
and other damaging luminal contents 
into the systemic circulation; inflamma-
tory mediators released by the enteric 
immune system have local intestinal and 
systemic effects. In this context, enteral 
nutrition, particularly with mother’s own 
milk, may actually play a beneficial role 
by influencing structural and functional 
integrity of the gut, reducing systemic 
inflammatory responses and promoting 
proliferation of gut microbial diversity. 
The limited available clinical data support 
this: a retrospective matched case–control 
study of 34 infants in the USA, which 
compared minimal enteral nutrition with 
withholding feeds during therapeutic 
hypothermia, found lower inflammatory 
cytokine concentrations and a reduc-
tion in days of parenteral nutrition and 
hospital stay in the enteral feeding group.2 
Similarly, a retrospective cohort study of 
85 infants that compared outcomes in the 
UK and Sweden where 33% vs 91% of 
infants received milk feeds during hypo-
thermia respectively, found no differ-
ences in clinical outcomes (and no cases 
of NEC in either group).3 Animal model 
data suggest that hypothermia may have a 
protective effect on the gut by attenuating 
the systemic oxidative stress response and 
reducing inflammation and metabolic 
injury.7 The sparse available clinical data 
support this supposition: a retrospective 
cohort study including 36 infants who 
received therapeutic hypothermia for 
HIE, and 32 historical controls who did 
not, found that infants in the therapeutic 
hypothermia cohort reached full milk 
feeds sooner; furthermore, three cases of 
NEC were reported—all in the histor-
ical (uncooled) cohort.8 In summary, the 
limited evidence suggests that following 
a hypoxic insult, both hypothermia and 
enteral feeding may have a protective 
effect on the gastrointestinal system and 
careful introduction of enteral feeds 
appears to be well tolerated and safe.
ParEntEral nutritiOn
In high-income settings, infants who 
receive therapeutic hypothermia receive 
some form of intravenous fluid support: 
commonly intravenous dextrose with 
electrolytes as required, or parenteral 
nutrition.1 This practice is also variable—
Hazeldine et al found that 29% (14/49) 
of responding UK neonatal units report 
routine use of parenteral nutrition.1 While 
dextrose provides sufficient carbohy-
drate energy to prevent hypoglycaemia, it 
does not limit catabolism as effectively as 
parenteral nutrition. This is the rationale 
for giving parenteral nutrition to infants 
receiving therapeutic hypothermia: to 
improve overall growth, brain growth and 
potentially neurodevelopment—although 
we note that this conjecture is not backed 
up by any human studies.
In critically ill adults and children the 
provision of early parenteral nutrition is 
increasingly controversial, with accumu-
lating evidence of harm caused by early 
parenteral nutrition. A systematic review of 
18 adult randomised controlled trials, with 
a total of 3347 patients, found no effect on 
mortality but significantly higher rates of 
infection and longer average length of stay 
in patients in the parenteral compared with 
enteral nutrition groups.9 The Early versus 
Late Parenteral Nutrition in the Pediatric 
Intensive Care Unit (PEPaNIC) trial reached 
a similar conclusion, that early provision of 
parenteral nutrition may be harmful. This 
trial randomised 1440 critically ill children 
(including 209 term neonates) to receive 
parenteral nutrition within 24 hours of 
admission, or for parenteral nutrition to be 
delayed for 7 days. While mortality rates 
were similar in the two groups, children 
who had parenteral nutrition withheld for 
7 days had a significantly lower rate of new 
infection (10.7% vs 18.5%).5 A preplanned 
secondary analysis of the 209 term neonates 
included in the PEPaNIC trial confirmed 
lower likelihood of infection and higher 
rate of survival to discharge in infants for 
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whom parenteral nutrition was withheld, 
but at the cost of an increased risk of hypo-
glycaemia.10 While these results are not 
directly applicable to term infants under-
going therapeutic hypothermia for HIE, for 
example, the majority of neonatal partici-
pants in the PEPaNIC trial were surgical 
patients, it does raise concerns about the 
potential harms of early parenteral nutri-
tion in term infants that require critical care 
generally.
The evidence to guide nutritional prac-
tice for term infants undergoing therapeutic 
hypothermia is based on a few small studies, 
with inherent risk of bias. This limited avail-
able evidence suggests that careful intro-
duction of enteral feeds during therapeutic 
hypothermia is safe, may beneficially modu-
late inflammatory responses and may be 
associated with earlier time to full enteral 
feeding and earlier discharge. Parenteral 
nutrition during critical illnesses in children 
and term neonates may do more harm by 
increasing the risk of serious infection and 
prolonging hospital stay—but the degree to 
which this is applicable to infants with HIE 
undergoing therapeutic hypothermia is not 
known.
Further research is needed to inform 
nutritional practice for this sizeable group 
of infants; an ongoing National Institute for 
Health Research funded study (https:// doi. 
org/ 10. 1186/ ISRCTN47404296, registered 
pre-results) aims to address this uncer-
tainty using UK population data held on 
the National Neonatal Research Database. 
Data from several thousand infants who 
received therapeutic hypothermia during a 
10-year period will be included. This study 
will form two groups that are matched on 
an extensive list of background variables 
using propensity scores. The intention of 
this approach is to reduce the risk of bias 
from confounders, facilitating the use of 
observational data to address the question 
‘what is the optimum enteral and parenteral 
nutrition strategy for newborns with HIE 
during therapeutic hypothermia?’ While we 
remain unsure of how to deliver nutrition to 
infants with HIE, it is imperative to consider 
that enteral feeding could be a beneficial 
adjunct to therapeutic hypothermia while 
parenteral nutrition, although a reliable 
vehicle for nutrient delivery, may increase 
the risk of infection.
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